Cleantech Capital Advisors is pleased to announce that its client OxyMem, a supplier of highly innovative membrane systems and solutions for the OpEx-efficient treatment of secondary wastewater streams, has received funding from the corporate venturing arm of Dow Chemicals. These proceeds will support OxyMem’s commercial rollout and working capital requirements. READ MORE